ONCOTHERAPY PRIVATE INVESTMENTS SL
Company details
- Active NIF/CIF: B67247858
-
-
-
-
Address: CL GRAN VIA DE LES CORTS CATALANES NUM702 PPR PT (BARCELONA)
-
-
Featured products:
More information on ONCOTHERAPY PRIVATE INVESTMENTS SL
-
17/05/2024 | BORME act no.: 225459 | Register: BARCELONAModificaciones estatutarias
-
02/11/2023 | BORME act no.: 464789 | Register: BARCELONAModificaciones estatutarias
-
23/05/2019 | BORME act no.: 219027 | Register: BARCELONAReducción de capital
-
23/05/2019 | BORME act no.: 219027 | Register: BARCELONAAmpliación de capital
-
16/07/2018 | BORME act no.: 293368 | Register: BARCELONAConstitución
-
16/07/2018 | BORME act no.: 293368 | Register: BARCELONANombramientos
Other information
The CIF assigned to ONCOTHERAPY PRIVATE INVESTMENTS SL is B67247858, and its current business status is active. The company is engaged in economic activities classified under the CNAE 6420 - Holding company activities, while its SIC - is also applicable. Regarding personnel, ONCOTHERAPY PRIVATE INVESTMENTS SL employs approximately Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona and has a total of 2 registered positions. The latest announcement of ONCOTHERAPY PRIVATE INVESTMENTS SL in the Borme was published on 17/05/2024, and its most recent ordinary annual accounts deposit is from the year 2022. To obtain contact information for ONCOTHERAPY PRIVATE INVESTMENTS SL, such as telephone number, postal address, or website, you can visit the Company Data module. If you wish to obtain more details about ONCOTHERAPY PRIVATE INVESTMENTS SL, you can review one of our available financial reports, examine the company's Annual Accounts, or check for any registered defaults in the RAI delinquency file. The financial, business, and legal information provided about ONCOTHERAPY PRIVATE INVESTMENTS SL is official and updated daily.
Do you want to know more about ONCOTHERAPY PRIVATE INVESTMENTS SL??
Find out more about this company by consulting these reports: